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Smoking and Elevated Blood Pressure Are the Most
Important Risk Factors for Subarachnoid Hemorrhage in
the Asia-Pacific Region
An Overview of 26 Cohorts Involving 306 620 Participants
Valery Feigin, MD, PhD; Varsha Parag, MSc (Hons); Carlene M. M. Lawes, MBChB, PhD;
Anthony Rodgers, MBChB, FAFPHM, PhD; Il Suh, MD, PhD, FAHA; Mark Woodward, PhD;
Konrad Jamrozik, MBBS, DPhil, FAFPHM; Hirotsugu Ueshima, MD;
on behalf of the Asia Pacific Cohort Studies Collaboration
Background and Purpose—The cause of subarachnoid hemorrhage (SAH) is poorly understood and there are few large
cohort studies of risk factors for SAH. We investigated the risk of SAH mortality and morbidity associated with common
cardiovascular risk factors in the Asia-Pacific region and examined whether the strengths of these associations were
different in Asian and Australasian (predominantly white) populations.
Methods—Cohort studies were identified from Internet electronic databases, searches of proceedings of meetings, and
personal communication. Hazard ratios (HRs) for systolic blood pressure (SBP), current smoking, total serum
cholesterol, body mass index (BMI), and alcohol drinking were calculated from Cox models that were stratified by sex
and cohort and adjusted for age at risk.
Results—Individual participant data from 26 prospective cohort studies (total number of participants 306 620) that reported
incident cases of SAH (fatal and/or nonfatal) were available for analysis. During the median follow-up period of 8.2
years, a total of 236 incident cases of SAH were observed. Current smoking (HR, 2.4; 95% CI, 1.8 to 3.4) and SBP
140 mm Hg (HR, 2.0; 95% CI, 1.5 to 2.7) were significant and independent risk factors for SAH. Attributable risks
of SAH associated with current smoking and elevated SBP (140 mm Hg) were 29% and 19%, respectively. There were
no significant associations between the risk of SAH and cholesterol, BMI, or drinking alcohol. The strength of the
associations of the common cardiovascular risk factors with the risk of SAH did not differ much between Asian and
Australasian regions.
Conclusions—Cigarette smoking and SBP are the most important risk factors for SAH in the Asia-Pacific region. (Stroke.
2005;36:1360-1365.)
Key Words: meta-analysis  risk factors  subarachnoid hemorrhage
Subarachnoid hemorrhage (SAH) constitutes 4% to 7% ofall strokes and, because of its high morbidity/mortality,1–3
is one of the most devastating subtypes of stroke.4 Although
previous studies have consistently indicated that cigarette
smoking is the most important modifiable risk factor for
SAH,5 the role of other common cardiovascular factors (eg,
levels of blood pressure, serum cholesterol, body mass index
[BMI], and alcohol intake) in the cause of SAH is poorly
defined and the existing findings are controversial.6–8 The
lack of knowledge on cause of SAH9 hampers its effective
prevention. Stroke registry studies in the Asia-Pacific region
indicate that the incidence of SAH is comparatively high in
Maori/Pacific10 and Japanese11,12 people but very low in
China13 and India,14 suggesting that risk factors (or their
prevalence and/or significance) for SAH in these populations
may be different from those in other regions. However, few
prospective data are available to provide reliable evidence to
examine this hypothesis, and no direct comparisons have
been made of the strength of the association of common
cardiovascular risk factors with SAH endpoints in the differ-
ent regions. Such information is crucial to estimating the
burden of SAH attributable to common cardiovascular risk
factors and, more importantly, the burden that is potentially
avoidable with the control of these risk factors at the
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population level. These estimates may also contribute to
understanding why the incidence rates of SAH in various
countries are relatively steady1,15 despite changes observed in
the prevalence of some common cardiovascular risk factors.
In addition, international comparisons are not possible within
individual cohort studies. Overviews, or meta-analyses, of
cohort studies can overcome these issues.
We sought to estimate the mortality and morbidity from
SAH associated with common cardiovascular risk factors in
the Asia-Pacific region, and to determine if the strength and
shapes of these associations with age and sex were different
in Asian and Australasian (predominantly white; Australia
and New Zealand) populations.
Participants and Methods
Identification of Studies and Collection of Data
The Asia Pacific Cohort Studies Collaboration (APCSC) is an
individual participant data overview (meta-analysis) of cohort stud-
ies in the Asia-Pacific region. Methods of study identification and
the characteristics of studies included have been reported else-
where.16 In brief, studies were eligible for inclusion in the project if
they satisfied the following criteria: (1) a study population from the
Asia-Pacific region; (2) prospective cohort study design; (3) at least
5000 person-years of follow-up recorded; (4) date of birth or age,
sex, and blood pressure recorded at baseline; and (5) date of death or
age at death recorded during follow-up.
In addition, data sought on individual participants included total
blood cholesterol, height, weight, cigarette smoking habit, and
alcohol consumption. However, because these variables were not
inclusion criteria for the collaboration, not all studies provided such
data. Outcome data for this report included first-ever-in-a-lifetime
SAH events (classified according to the ICD-9 code 430), whether
fatal or nonfatal, that occurred during the follow-up period. Nonfatal
events were defined as those that did not result in death within 28
days. In 7 studies (235 083 participants) that provided information,
the diagnosis of SAH was based on CT/MRI scanning, brain autopsy,
or cerebrospinal fluid examination in 84% of cases.
Statistical Analysis
Only those cohorts that provided data on baseline systolic blood
pressure (SBP), blood cholesterol, BMI, smoking habit, and alcohol
drinking were included in the analyses. All analyses were further
restricted to participants aged 20 years or older. BMI was calculated
as weight (kg) divided by the square of height (m). The available
data only permitted analysis of smoking and alcohol drinking habits
as categorical variables: current versus not current (includes former
and never). For the Melbourne cohort, current drinkers included
ever-drinkers. Analyses were undertaken for total (fatal and nonfatal)
SAH events, and sensitivity analyses examined fatal SAH events
only.
Stratified Cox proportional hazards analyses17 were used to
regress time until first event against baseline cardiovascular risk
factors. All analyses were stratified by sex and cohort to control for
confounding and reduce statistical heterogeneity. Age at risk (age at
the time of the event) was treated as an external time-dependent
covariate18 to assess change in hazards as an individual’s age
increased. The hazard ratios and corresponding 95% CI for individ-
ual risk factors were adjusted for all other risk factors analyzed.
Usual associations for SBP and cholesterol were estimated by
adjusting for regression dilution bias.19 Repeat measurements of SBP
and serum cholesterol available from 7 cohorts were used to estimate
regression dilution factors (SBP1.8 and cholesterol1.7) using
mixed models that took into account the varying time intervals
between measurements.19
As well as examining SBP, cholesterol, and BMI on a continuous
scale, these risk factors were divided into the following dichoto-
mized groups (based on both sample sizes and clinical usefulness of
the levels); SBP, 140 and 140 mm Hg; cholesterol, 4.5 and
4.5 mmol/L; and BMI, 22 and 22 kg/m2. Attributable risks,
adjusted for other risk factors, were calculated using population-
attributable fractions20–22 for these categories and for current smok-
ing and drinking. To assess the shape of the associations, additional
analyses were conducted dividing baseline SBP, cholesterol, and
BMI into the following quartiles: SBP (115, 115 to 129, 130 to
144, 145 mm Hg), cholesterol (4.0, 4.0 to 4.9, 5.0 to 5.9,
6.0 mmol/L), and BMI (22.0, 22.0 to 23.9, 24.0 to 25.9, 26.0
kg/m2). Ninety-five percent CIs for each quartile were estimated
using the “floating absolute risk” method, which avoids the use of an
arbitrary reference group.21,22
Age-specific analyses included age at risk categories younger than
55 and 55 years or older, and analyses were also conducted by sex
and region (Asia versus Australasia). Effect modification was as-
sessed with the use of statistical interaction terms for age, sex, and
region in the Cox model. Further sensitivity analyses investigated the
impact of excluding the Korea Medical Insurance Corporation
(KMIC) cohort study from the analyses, because it contributed the
largest number of SAH events in this report, and cases diagnosed on
clinical findings only.
Results
The analyses were based on 26 cohorts from APCSC that
provided data on nonfatal and/or fatal SAH events and
baseline SBP, cholesterol, BMI, smoking, and alcohol
drinking habits (Table 1). In total, 306 620 participants
contributed 1 898 565 person-years of follow-up. The
Asian cohorts tended to have lower means than the
Australasian cohorts for SBP, cholesterol, and BMI (Table
2). No significant differences in mean diastolic blood
pressure levels were found between the Asian (78.9 SD
10.9 mm Hg) and Australasian (77.4 SD 12.1 mm Hg)
cohorts. Proportionately more Asian participants were
current smokers (except Asian women; sex-specific data
not shown in Table 2) and fewer drank alcohol compared
with Australasian participants.
Among the 5 risk factors analyzed, SBP and smoking
were the only significant risk factors for total SAH events
(Figure 1). Overall, the hazard ratio for SBP 140 mm Hg
was 2.0 (95% CI, 1.5 to 2.7), and that for current smoking
was 2.4 (95% CI, 1.8 to 3.4). The significance of elevated
SBP was more pronounced in younger subjects and in
females compared with males. However, these differences
were not statistically significant. The association between
SBP and risk of SAH was not significantly different
between Asian and Australasian subjects. The risk of total
SAH increased steeply with level of SBP (Figure 2).
Overall, a 10-mm Hg difference in SBP was associated
with a 31% (95% CI, 23 to 38) difference in risk of total
SAH. The hazardous effect of current smoking on the risk
of total SAH occurrence was not dependent on age, sex, or
region. The attributable risks associated with current
smoking and elevated SBP (140 mm Hg) were 29%
(95% CI, 21% to 35%) and 19% (95% CI, 13% to 24%),
respectively.
No significant associations were found between choles-
terol, BMI, or alcohol drinking with the risk of total SAH
events (Figures 1 and 2). Overall, the hazard ratio for
cholesterol 4.5 mmol/L compared with 4.5 mmol/L
was 0.9 (95% CI, 0.7 to 1.3), BMI 22 kg/m2 compared
with 22 kg/m2 was 1.0 (95% CI, 0.7 to 1.3), and current
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drinking compared with not drinking was 1.0 (95% CI 0.7
to 1.4). Confining analyses to fatal SAH events or to
events with objective confirmation of hemorrhage, or
excluding the KMIC cohort study (either from the overall
data or just from the Asian data), or excluding studies with
no SAH events did not statistically significantly alter our
results.
Discussion
To our knowledge, this project is the first large-scale
individual participant SAH data overview of risk factors
for SAH in cohorts from the Asia-Pacific region. Overall,
Asians tended to have lower means for SBP, cholesterol,
and BMI, and fewer were alcohol drinkers, but there were
more current male smokers compared with Australians and
New Zealanders. This research extends findings from other
epidemiological studies of SAH. First, we found that
cigarette smoking and elevated SBP are the most important
risk factors, each of which doubles the risk of SAH in the
Asia-Pacific region. Whereas the hazardous effect of
cigarette smoking was strikingly consistent across all strata
defined by age, sex, and region, the association with
elevated SBP was more pronounced in younger subjects
(younger than 55 years) and in women. Second, we
detected no associations between the risk of SAH and
cholesterol level, BMI, or alcohol drinking. Third, this is
the first study to show that the associations of the common
cardiovascular risk factors with the risk of SAH did not
differ much between Asian and Australasian regions.
Major strengths and limitations of the APCSC study
have been described elsewhere.23,24 In brief, the APCSC
provides a large and unique set of individual participant
database involving Asian cohorts and both men and
women. The combination of data from a number of Asian
and Australasian cohorts results in a relatively large
number of SAH events, thus providing precise estimates of
risk factor–SAH associations by region (Asia versus Aus-
tralasia). Analyzing SBP, cholesterol, and BMI levels as
categorical and continuous variables adjusted for each
other and for regression dilution bias is a particular
TABLE 1. Characteristics of Cohorts
Country Study Name No.
Start
Year
Median
Follow-up,
y
Female
(%)
Baseline Age, y Fatal
SAH
Events
Total
SAH
EventsMean Range
Japan Aito Town 1109 1980 16.4 59 51 21–73 0 0
Akabane 1830 1985 11.0 56 54 40–69 2 5
Civil Service Workers 9217 1991 6.7 33 47 40–55 1 1
Hisayama 1460 1961 25.1 56 56 40–91 19 26
Konan 1188 1987 6.4 55 52 20–96 2 2
Miyama 412 1988 6.6 62 59 41–80 0 0
Ohasama 1872 1992 4.1 64 58 27–91 1 5
Saitama 3582 1986 11.0 62 54 20–94 11 11
Shibata 2308 1977 20.0 58 57 40–89 13 13
Shigaraki Town 3641 1991 4.4 59 57 29–95 5 5
China Fangshan 828 1992 2.7 67 47 34–72 0 0
Guangzhou Occupational 4503 1987 7.9 32 43 29–87 0 0
Huashan 1792 1992 2.8 52 53 35–76 0 0
Seven Cities 6346 1987 2.7 57 58 35–91 3 5
Six Cohorts 14 486 1982 8.4 48 45 35–59 2 4
Yunnan 2626 1992 4.5 4 54 36–81 0 0
Taiwan CVDFACTS 5525 1989 6.0 56 47 20–92 0 0
South Korea KMIC 159 151 1992 4.0 33 44 35–59 22 106
Singapore Singapore Heart 2277 1982 14.6 49 41 20–89 0 0
Singapore NHS92 3302 1992 6.2 52 39 20–70 0 2
Australia Australian National Heart Foundation 9100 1989 8.3 51 43 20–70 3 3
Busselton 6997 1966 21.6 52 45 20–94 9 21
Melbourne 41 122 1990 8.5 59 55 27–75 13 13
Newcastle 5799 1983 8.7 50 52 21–77 0 0
Perth 5981 1980 8.4 49 45 20–70 3 3
New Zealand Fletcher Challenge 10 166 1992 5.8 28 44 20–89 5 11
Total or average* 306 620 8.2 45 48 20–96 114 236
*Averages weighted by person-years of follow-up (total person-years of follow-up was 1 898 565).
Zero events means that no SAH events were recorded during the follow-up period.
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methodological strength of this study. Another important
advantage is the high proportion of cases with objective
confirmation of SAH, thus minimizing misclassification
bias. However, we were not able to evaluate ethnic-
specific associations of risk factors with SAH or to
examine the association between different levels of ciga-
rette smoking and alcohol drinking on the risk of SAH.
The absence of substantial gender differences in the
significance of risk factors for SAH, the attenuation with
age of the association with SBP, and the lack of a
significant association between cholesterol levels and SAH
are in line with our previous analyses on risk factors for
intracerebral hemorrhage,23,24 suggesting some similarities
in the pathogenesis of the 2 major subtypes of hemorrhagic
stroke. The strong and positive association between base-
line level of SBP and the risk of SAH concur with those
found between “usual” level of SBP and the risk of
ischemic stroke and intracerebral hemorrhage in the Asian-
Pacific region.23 Unlike previous findings of continuous
positive relationships between baseline BMI and the risk
of both ischemic stroke and intracerebral hemorrhage in
the Asia–Pacific region,25 there were no such associations
with SAH. Our findings did not support some other
observations that lean BMI5 and low total cholesterol8,26
are associated with greater risk of SAH. Although it is
possible that the low cutoff points used in our analyses
may have contributed to the lack of the associations
between BMI, total cholesterol, and SAH, sensitivity
analyses using different cutoff points consistently found no
associations. Strong positive associations between occur-
rence of SAH and smoking and elevated blood pressure but
no significant associations with BMI, alcohol consump-
tion, and total serum cholesterol in men were also found in
the KMIC Study.7
Our results indicated that up to 19% of cases of SAH in
the region were attributable to systolic blood pressure
140 mm Hg and 29% of cases of SAH were attributable
to smoking. This suggests that a substantial proportion of
SAH events could potentially be prevented by reducing
blood pressure and smoking at a population level. Overall,
each 10 mm Hg decrease in mean SBP is expected to result
in a reduction in SAH of 31%. That the risk of SAH
associated with SBP varies with age and gender has
emphasized the importance of blood pressure control
programs in young subjects (younger than 55 years) and in
women. More generally, our findings of the significance of
current smoking and elevated blood pressure as risk factors
for SAH concur with results from other investigations in
the Asia–Pacific region7,23,27,28 and elsewhere.6 Exposure
to these risk factors individually and/or in combination
promotes formation, growth, and rupture of intracranial
aneurysm(s)29 –31— a major cause of SAH. The consistency
of the data across studies involving different designs and
populations suggests that cigarette smoking and elevated
blood pressure are causally related to SAH.
Appendix Asia Pacific Cohort
Studies Collaboration
Writing committee: V. Feigin, V. Parag, C.M.M. Lawes, A. Rodgers,
I. Suh, M. Woodward, K. Jamrozik, H. Ueshima.
Statistical Analyses
V. Parag, R.B. Lin, S. Vander Hoorn, D.A. Bennett, F. Barzi, M.
Woodward.
Figure 1. Dichotomized risk factor groups and the risk of total SAH events, overall and by age at risk, sex, and region subgroups. The
hazard ratios for total SAH events adjusted for age at risk and stratified by sex and cohort, plotted on a log scale for 5 risk factors. The
hazard ratios for individual risk factors were adjusted for all other risk factors analyzed and for regression dilution bias. The solid
squares are drawn in proportion to the inverse of the variance, and the horizontal lines represent 95% confidence intervals. The risk
factors have been dichotomized into the following groups: SBP, 140 (reference) and 140 mm Hg; cholesterol, 4.5 (reference) and
4.5 mmol/L; BMI, 22 (reference) and 22 kg/m2; and smoking and drinking, not current (reference) and current. For each risk factor,
hazard ratios have been given overall and by age at risk, sex, and region subgroups.
TABLE 2. Mean (or Percentage) Values of Major Risk Factors
by Region
Risk Factor Asia Australasia Overall
SBP, mm Hg
Mean (SD) 123.0 (16.6) 134.0 (20.6) 125.8 (18.4)
140, no. (%) 192 547 (85) 52 753 (65) 244 300 (80)
Cholesterol, mmol/L
Mean (SD) 4.9 (1.0) 6.6 (1.1) 5.1 (1.0)
4.5, no. (%) 76 268 (34) 12 541 (16) 88 809 (29)
BMI, kg/m2
Mean (SD) 22.9 (2.8) 26.4 (4.4) 23.8 (3.6)
22, no. (%) 90 160 (40) 11 213 (14) 101 373 (33)
Smoking
Current, no. (%) 85 188 (37) 14 440 (18) 99 628 (33)
Drinking alcohol
Current, no. (%) 107 007 (47) 59 443 (75) 166 450 (54)
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